Italian Life Sciences Database

Study achieved key objectives for safety, efficacy and pharmacokinetics;After completion of the study, all patients enrolled in an extension study;Treatment with PRX-102 provided coverage for the entire four?week period between infusions;No patients developed treatment-induced anti-drug antibodies... Read more ››

By: PR Newswire Association LLC. - 18 Mar 2022

Related companies: Chiesi Farmaceutici SpA | Chiesi Pharmaceuticals B.V. | Chiesi Ventures

Annual General Meeting in ALK-Abelló A/S held on 16 March 2022

By: GlobenewsWire - 16 Mar 2022

Decision to complete share split at a ratio of 1:20

By: GlobenewsWire - 16 Mar 2022

Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Officer

By: GlobenewsWire - 16 Mar 2022

Related companies: Kither Biotech

BodiMetrics' Prevention circul+ Ring Sleep Apnea Detection Comparable to Sleep Lab Tests

By: PR Newswire Association LLC. - 15 Mar 2022

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 14 Mar 2022

Novo Nordisk – major shareholder announcement

By: GlobenewsWire - 14 Mar 2022

Digital Medicine Society Rallies Global Healthcare Leaders to Collaborate on Digital Measurement for Alzheimer's Disease

<legend role="h2">Collaboration marks an ambitious step toward advancing therapies for Alzheimer's disease and related dementias</legend> Read more ››

By: PR Newswire Association LLC. - 14 Mar 2022

Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

By: GlobenewsWire - 09 Mar 2022

Related companies: Genenta Science s.r.l.

Shoreline Biosciences to Present Multiple Posters on iPSC-Derived NK Cell Platform at AACR Annual Meeting 2022

By: PR Newswire Association LLC. - 09 Mar 2022

Related companies: Shoreline Soc. Coop | Shoreline Biome, LLC | Shoreline Biosciences | Shoreline Venture Management, LLC

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 07 Mar 2022

European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease

- First CE-IVD-marked blood test that predicts likely progression to Alzheimer's disease up to six years in advance of definitive symptoms;- Received Breakthrough Device designation from U.S. FDA;- Investment supported by European Guarantee Fund's Venture Debt Loan Programme Read more ››

By: PR Newswire Association LLC. - 07 Mar 2022

Related companies: Diadem srl.

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2022
- The Pharma Business Development Course with Stefan Fischer
July 2022
- Piscataway: Bio-Manufacturing Innovation Summit
- BIO Asia-Taiwan

See Events »

Add an Event »

Latest company news

IR-Med To Initiate Useability Study of its PressureSafe Device
23 Jun 2022 (GlobenewsWire)

CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma
23 Jun 2022 (PR Newswire Association LLC.)

AMRA Biomarkers Indicate Individuals with CVD and T2D Have Faster Muscle Deterioration than Metabolically Disease-Free People -- AMRA Medical to Present Data at SCWD
23 Jun 2022 (PR Newswire Association LLC.)

News in the Life Sciences Industry

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news